Jamieson Bondarenko - Net Worth and Insider Trading
Jamieson Bondarenko Net Worth
The estimated net worth of Jamieson Bondarenko is at least $169,856 dollars as of 2024-11-10. Jamieson Bondarenko is the Director of BriaCell Therapeutics Corp and owns about 169,856 shares of BriaCell Therapeutics Corp (TSX:BCT) stock worth over $169,856. Details can be seen in Jamieson Bondarenko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jamieson Bondarenko has not made any transactions after 2022-12-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jamieson Bondarenko
Jamieson Bondarenko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jamieson Bondarenko owns 1 companies in total, including BriaCell Therapeutics Corp (TSX:BCT) .
Click here to see the complete history of Jamieson Bondarenko’s form 4 insider trades.
Insider Ownership Summary of Jamieson Bondarenko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:BCT | BriaCell Therapeutics Corp | 2022-12-28 | Director |
Jamieson Bondarenko Latest Holdings Summary
Jamieson Bondarenko currently owns a total of 1 stock. Jamieson Bondarenko owns 169,856 shares of BriaCell Therapeutics Corp (TSX:BCT) as of December 28, 2022, with a value of $169,856.
Latest Holdings of Jamieson Bondarenko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:BCT | BriaCell Therapeutics Corp | 2022-12-28 | 169,856 | 1.00 | 169,856 |
Holding Weightings of Jamieson Bondarenko
Jamieson Bondarenko Form 4 Trading Tracker
According to the SEC Form 4 filings, Jamieson Bondarenko has made a total of 2 transactions in BriaCell Therapeutics Corp (TSX:BCT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in BriaCell Therapeutics Corp is the acquisition of 28,000 shares on December 28, 2022, which cost Jamieson Bondarenko around $175,426.
Insider Trading History of Jamieson Bondarenko
- 1
Jamieson Bondarenko Trading Performance
GuruFocus tracks the stock performance after each of Jamieson Bondarenko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jamieson Bondarenko is 20.14%. GuruFocus also compares Jamieson Bondarenko's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jamieson Bondarenko within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jamieson Bondarenko's insider trading performs compared to the benchmark.
Performance of Jamieson Bondarenko
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.03 | | | | | |
| Relative Return to S&P 500(%) | 17.48 | | | | | |
Jamieson Bondarenko Ownership Network
Ownership Network List of Jamieson Bondarenko
Ownership Network Relation of Jamieson Bondarenko
Jamieson Bondarenko Owned Company Details
What does BriaCell Therapeutics Corp do?
Who are the key executives at BriaCell Therapeutics Corp?
Jamieson Bondarenko is the Director of BriaCell Therapeutics Corp. Other key executives at BriaCell Therapeutics Corp include 10% Security Holder & Director Marc Lustig , Senior Officer Gadi Levin , and Director & Senior Officer WILLIAM WILLIAMS .
BriaCell Therapeutics Corp (TSX:BCT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BriaCell Therapeutics Corp (TSX:BCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BriaCell Therapeutics Corp (TSX:BCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BriaCell Therapeutics Corp (TSX:BCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
BriaCell Therapeutics Corp Insider Transactions
Jamieson Bondarenko Mailing Address
Above is the net worth, insider trading, and ownership report for Jamieson Bondarenko. Currently GuruFocus does not have mailing address information for Jamieson Bondarenko.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
